MAXIM PHARMACEUTICALS INC
10-K, EX-27, 2000-12-28
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: MAXIM PHARMACEUTICALS INC, 10-K, EX-23.1, 2000-12-28
Next: MORGAN J P COMMERCIAL MORTGAGE FINANCE CORP, 8-K, 2000-12-28



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 1999 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               SEP-30-2000
<CASH>                                      72,627,089
<SECURITIES>                               117,737,740
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                           195,561,471
<PP&E>                                       5,515,226
<DEPRECIATION>                               1,481,984
<TOTAL-ASSETS>                             232,994,066
<CURRENT-LIABILITIES>                       15,502,607
<BONDS>                                      1,541,968
                                0
                                          0
<COMMON>                                        23,116
<OTHER-SE>                                 215,926,375
<TOTAL-LIABILITY-AND-EQUITY>               232,994,066
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            36,387,151
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              91,615
<INCOME-PRETAX>                             82,501,885
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                82,501,885
<EPS-BASIC>                                       4.58
<EPS-DILUTED>                                     4.58


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission